Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

OBJECTIVE: Since dermatomyositis (DM) is associated with an increased risk of malignancy, accurate identification of patients likely to harbor cancers is important. Using immunoprecipitations from radiolabeled cell lysates, several groups recently showed that anti–transcription intermediary factor 1...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Fiorentino, David F., Chung, Lorinda S., Christopher-Stine, Lisa, Zaba, Lisa, Li, Shufeng, Mammen, Andrew L., Rosen, Antony, Casciola-Rosen, Livia
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073292/
https://ncbi.nlm.nih.gov/pubmed/24037894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38093
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi